Guy-Charles FANNEAU DE LA HORIE, Directeur exécutif / CEO

Alain Huriez, Directeur exécutif / CEO , Directeur général (DG) / Managing Director

Philippe Pouletty, Président du CA

06/09/2010 - 2010: A GOOD YEAR FOR IPOs

Stock market registrations in Europe seem to have picked up speed in Q2 2010. While 2009 was less than remarkable in that respect,… (n°472, EUROPE, page 1)

06/09/2010 - A RECEPTIVE BUT CAUTIOUS MARKET

“H1 2010 has been particularly paradoxical. On one hand we have observed several successful developments, such as the stock market flotations"… (n°472, FRANCE, page 3)

05/07/2010 - Novagali in the center of the action

The wave of IPOs, which started mid-April with Neovacs, continues to gain momentum with the application of the sixth biotech company within less than three months… (n°469, BREAKING NEWS, page 1)

21/06/2010 - Market shock: IntraGen opts for direct listing

IntraGen has provided the surprise of the week by entering the stock market by direct listing on Alternext, following in the footsteps of Genfit, from Lille, a few years ago…
(n°467, BREAKING NEWS, page 1)

14/06/2010 - BMD Therapies get boost from BMD

Biomedical Diagnostics (BMD), a specialist in diagnostics since 1986, has steadily increased its product range to supply clinicians with more and more innovative tools… (n°466, Interview, page 6)

31/05/2010 - For whom does the bell of austerity toll?

We can’t help wondering about the austerity plans that are coming into force all over Europe; their impact on the IPOs of the future;… (n°464, BREAKING NEWS, page 1)

24/05/2010 - “We need to close the gap between private equity and the European stock market”

Now that the biotechnology industry is on the brink of becoming profitable, as stated in Ernst & Young’s latest report “Beyond Borders: Global Biotechnology 2010”… (n°463, Expertise, page 6)

03/05/2010 - IPOs Europe: Truffle Capital gets IPO break

Truffle Capital, the French private equity mutual fund (FCPR) specialized in innovative companies (FCPI), with 400 M€ under its management,… (n°461, BREAKING NEWS, page 1)

22/03/2010 - IPO: Neovacs takes pole position in France

Neovacs has the green light for the stock exchange! It’s all in the bag, after the authorization given by the French financial market regulator AMF on March 18th... (n°455, BREAKING NEWS, page 0)

12/01/2009 - Le second semestre 2008 a été marqué par un ralentissement de l'investissement en capital dans les biotechnologies

Le second semestre 2008 a été très calme pour le financement des biotechnologies en France. 40 M€ auraient été... (n°401, FRANCE, page 3)